These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10360669)

  • 1. European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.
    Launonen V; Laake K; Huusko P; Niederacher D; Beckmann MW; Barkardottir RB; Geirsdottir EK; Gudmundsson J; Rio P; Bignon YJ; Seitz S; Scherneck S; Bièche I; Champème MH; Birnbaum D; White G; Varley J; Sztán M; Olah E; Osorio A; Benitez J; Spurr N; Velikonja N; Peterlin B; Winqvist R
    Br J Cancer; 1999 May; 80(5-6):879-82. PubMed ID: 10360669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.
    Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R
    Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
    Devilee P; Hermans J; Eyfjörd J; Bøorresen AL; Lidereau R; Sobol H; Borg A; Cleton-Jansen AM; Oláh E; Cohen BB; Scherneck S; Hamann U; Peterlin B; Caligo M; Bignon YJ; Maugard C
    Genes Chromosomes Cancer; 1997 Mar; 18(3):193-9. PubMed ID: 9071572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
    Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
    Hansen LL; Yilmaz M; Overgaard J; Andersen J; Kruse TA
    Cancer Res; 1998 May; 58(10):2166-9. PubMed ID: 9605761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer.
    Tomlinson IP; Nicolai H; Solomon E; Bodmer WF
    J Pathol; 1996 Sep; 180(1):38-43. PubMed ID: 8943813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L; Chen J; Du Q; Dumanski J; Blennow E; Kockum I; Luthman H; Lindblom A
    Int J Mol Med; 2002 Apr; 9(4):405-9. PubMed ID: 11891537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.
    Harima Y; Harima K; Sawada S; Tanaka Y; Arita S; Ohnishi T
    Clin Cancer Res; 2000 Mar; 6(3):1079-85. PubMed ID: 10741737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
    Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
    Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.